Experiment 387866

Details

PropertyValue
Pharmacology
Administration routeEXTERNAL
OrganismAloe vera (LILIACEAE)
CitationWILLIAMS,MS: BURK,M: LOPRINZI,CL: HILL,M: SCHOMBERG,PJ: NEARHOOD,K: O'FALLON,JR: LAURIE,JA: SHANAHAN,TG: MOORE,RL: URIAS,RE: KUSKE,RR: ENGEL,RE: EGGLESTON,WD:. (1996). PHASE III DOUBLE-BLIND EVALUATION OF AN ALOE VERA GEL AS A PROPHYLACTIC AGENT FOR RADIATION-INDUCED SKIN TOXICITY.. 36(2)
Amount utilized
Compound isolated
DiseaseTWO PHASE III RANDOMIZED TRIALS WERE CONDUCTED. THE FIRST ON WAS DOUBLE BLINDED, UTILIZED A PLACEBO GEL, AND INVOLVED 194 WOMEN RECEIVING BREAST OR CHEST WALL IRADIATION. THE SECOND TRIAL RANDOMIZED 108 SUCH PATIENTS TO ALOE VERA GEL VS.NO TREATMENT. SKIN DERMATITIS WAS SCORED WEEKLY DURING BOTH TRIALS BOTH BY PATIENTS AND BY HEALTH CARE PROVIDERS. SKIN DERMATITIS SCORES WERE VIRTUALLY IDENTICAL ON BOTH TREATMENT ARMS DURING BOTH OF THE TRIALS. THE ONLY TOXICITY FROM THE GEL WAS RARE CONTACT DERMATITIS. THIS DOSE AND SCHEDULE OF AN ALOE VERA GEL DOES NOT PROTECT AGAINST RADIATION THERAPY-INDUCED DERMATITIS. A COMMERCIAL PREPARATION OF THE GEL WAS USED IN THIS STUDY.
Number1
Qualitative resultINACTIVE
AnimalHUMAN ADULT
Dose expressionDOSE
ExtractH2O EXT
GenderFEMALE